instances of systemic reactions resembling anaphylaxis have been reported in association with PBPC reinfusion; these reactions are frequently attributed to the presence of Anaphylaxis has been reported in subjects receiving peripheral blood precursor cell (PBPC) infusions; howdimethyl sulfoxide (DMSO) (in the cryopreserved cell preparations. [3] [4] [5] However, in vivo experience with DMSO ever the etiologic agent is unclear. Basophils from a PBPC-allergic subject were challenged with each indihas shown no association with anaphylactic reactions, and in vitro studies suggest that DMSO may actually inhibit vidual component of the stem cell infusion and with recombinant human (rh)DNAse. Histamine release data mediator release from both mast cells and basophils. 6,7 Thus, the pathogenesis of systemic reactions associated were compared with those using basophils from control subjects. Histamine release assays were repeated using with PBPC infusions remains unclear.
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Thus, the pathogenesis of systemic reactions associated were compared with those using basophils from control subjects. Histamine release assays were repeated using with PBPC infusions remains unclear.
We report herein the case of a subject with documented basophils from a control subject passively sensitized with serum IgE from the patient. Skin testing with bovanaphylaxis during two consecutive PBPC reinfusions. In vitro testing revealed IgE-mediated sensitivity to bovine ine DNAse was performed using standard techniques. Basophil histamine release occurred in the patient, but DNAse (commonly used to inhibit cellular aggregation), without crossreactivity to commercially available not in controls, with bovine DNAse. No release could be provoked by any of the other components of the infusrhDNAse, and no IgE-related sensitivity to DMSO. ate; no release could be detected with rhDNAse. Sensitivity to bovine DNAse could be transferred to basophils from a control subject with the serum IgE from the Case presentation patient. Marked epicutaneous skin test reactivity to bovine DNAse was evident in the patient, but not in control A 50-year-old female presented in November 1995 with primary peritoneal carcinoma and a CA-125 of 1037 IU/ml. subjects. We conclude that systemic reactions during peripheral blood precursor cell infusions may represent
In December 1995, the patient began a regimen for mobilization of peripheral blood stem cells. Subsequent administrue IgE-mediated anaphylaxis to bovine DNAse in the infusate. Skin testing can detect such sensitivity, and the tration of high-dose carboplatin and paclitaxel in February 1996 was complicated by a hypersensitivity response to use of rhDNAse may obviate such reactions. Keywords: anaphylaxis; stem cell; IgE; DNAse; basopaclitaxel which was managed successfully utilizing newly published guidelines. 8 The patient's first stem cell reinphils fusion occurred 3 days later. Within 5 min of starting, the patient developed flushing with severe pruritus, gastrointestinal distress, shortness of breath, bronchospasm, tachyThe use of autologous peripheral blood progenitor cells cardia, profound hypotension, and altered sensorium. The (PBPCs) for bone marrow reconstitution in the treatment patient required intubation with assisted ventilation, pressor of hematologic and specific solid malignancies has gained support, and crystalloid infusion, but recovered after several considerable popularity. Utilizing high-efficiency cell sephours without sequellae. She received the remainder of her arators with or without mobilization of stem cells with hemstem cell reinfusion while intubated and on pressors. Wishatopoietic growth factors, high yields of progenitor cells ing for another cycle of chemotherapy, the patient again may be obtained for either immediate use or cryopreservreceived high-dose carboplatin and paclitaxel, followed by ation. 1 cell reinfusion. Urinary methylhistamine, performed on m to 3 × 10 −8 m). The highest concentration tested for each spot urines throughout the day, were normal during the agent was approximately 10-fold higher than the concen-'DMSO desensitization' (14 ng/ml), but became elevated trations in the actual infusions administered to patients. immediately following the systemic reaction (96 ng/ml, Control cell aliquots were challenged with anti-IgE. The normal range 9-48 ng/ml). A subsequent CA-125 was 16, histamine released was measured using the automated fluoand CT scans showed no measurable disease.
rometric technique of Siraganian. 11 Spontaneous histamine The patient denied any significant past medical history, release was assessed with cells in buffer alone; total histaincluding seasonal or drug-related allergies. However, her mine content was obtained by lysis with 2% perchloric past allergic history was significant for five previous epiacid. All assay conditions were performed in duplicate, sodes of mild to moderate flushing, tachycardia, dizziness, with replicates consistently showing Ͻ10% difference. and gastrointestinal distress following ingestion of various Results are expressed as the percentage of histamine foods. An extensive allergic evaluation 4 years previously released after subtracting spontaneous release of unstimurevealed no clear sensitivities, and an evaluation for carcilated samples from the total histamine content. noid syndrome was negative.
Passive sensitization
Lactic acid elution of IgE from the basophils of a control Materials and methods subject, followed by passive sensitization with IgE from the patient, was performed as previously described. 12 Briefly, Materials washed basophils from a control subject were incubated at 23°C for 3.5 min in 0.01 m lactic acid, pH = 3.9 (containing The following items were purchased: PIPES, bovine 140 mm NaCl and 5 mm KCl), diluted, washed in PAG, DNAse, DMSO, CPDA-1 (Sigma Chemical, St Louis, MO, incubated with patient serum at 37°C for 90 min, washed USA); crystalline human serum albumin (HSA) in PAG, and diluted in PAGCM for histamine release (Calbiochem, La Jolla, CA, USA); ethylenediaminetetraassays as described. acetic acid (EDTA), 60% perchloric acid, and dextrose (Fisher Scientific, Fair Lawn, NJ, USA); Medium 199 (Life Technologies, Grand Island, NY, USA); and rhDNAse Skin testing (Genentech, South San Francisco, CA, USA). Goat antiEpicutaneous and intradermal skin tests were performed human IgE was prepared as previously described. 9 using standard protocols with saline (negative control), histamine (positive control), and bovine DNAse on the patient and two control subjects. 13 All subjects had avoided the Buffers use of antihistamines for at least 2 weeks at the time of skin testing. Pipes (P) buffer contains 25 mm piperazine-N,N′-bis (2-ethane-sulfonic acid), 110 mm sodium chloride, and 5 mm potassium chloride, pH = 7.4. PAG buffer contains an Statistical analysis additional 0.1% dextrose and 0.003% HSA. PAGCM buffer, used during release experiments, is PAG containing
Results are expressed as the mean ± standard error of the 1 mm calcium and 1 mm magnesium. mean (s.e.m.) of duplicate cultures at each condition for the patient or control subjects.
Preparation of peripheral blood basophils
Results All blood donors provided informed consent for these studies. Venous blood was obtained from the patient, as well Skin testing as from atopic and nonatopic volunteer controls, and processed as previously described. 10 Briefly, blood was drawn The patient and two control subjects underwent epicutaneous skin testing with saline (negative control), histamine into a heparinized syringe and combined to a final concentration of 0.008 m EDTA and 1.1% dextran. Erythrocytes (positive control), and bovine DNAse at 10 −2 mg/ml. None of the individuals tested showed a response to saline. Both were allowed to sediment for approximately 90 min at room temperature prior to harvesting the leukocyte-rich upper control subjects showed positive wheal and flare responses to histamine without responses to bovine DNAse. The layer. These leukocytes were pelleted at 150 g for 8 min, washed twice with PAG, and resuspended in PAGCM for patient showed a response to bovine DNAse approximately two to three times the size of her response to histamine. subsequent histamine release experiments.
Basophil histamine release
from the patient using bovine DNAse and rhDNAse as stimuli. Once again, anti-IgE induced 54% histamine Basophil histamine release results from the patient and two release from the patient's cells. While bovine DNAse control subjects using bovine DNAse as a stimulus are caused significant histamine release from the patient's basoshown in Figure 1a . The anti-IgE-induced release from the phils, no release could be detected using rhDNAse up to patient's basophils was 54%; the anti-IgE responses of the 10 −2 mg/ml; higher concentrations of rhDNAse were not control subjects were 27% and 44%. While bovine DNAse tested. caused significant histamine release from the patient's baso- Figure 1c depicts the results of lactic acid elution and phils (EC 50 = 10 −6 mg/ml), no release could be detected passive sensitization of a control subject's basophils with from the basophils of control subjects at concentrations up the patient's serum IgE. The anti-IgE response of the conto 10 −2 mg/ml. No significant histamine release was trol subject was 47% before lactic acid elution and 13% detected in any of the three subjects when tested with up after this treatment. While no significant histamine release to a 10-fold excess of each of the other components of the could be elicited by bovine DNAse prior to passive sensitiz-PBPC infusate, including DMSO. ation, significant release was evident at all concentrations Figure 1b depicts the basophil histamine release results tested following passive sensitization with the patient's serum; this release was quantitatively similar to that seen with the patient's cells at the same concentrations of bovine DNAse.
Discussion
The use of DNAse in cryopreservation is based on its ability to inhibit cellular aggregation and the complications this may cause upon PBPC reinfusion. In most protocols, DNAse is added to freshly harvested PBPCs as a component of the freezing medium (Medium TC199 with DMSO 20% vol/vol, autologous plasma 10% vol/vol, and DNAse 300 units); freezing medium and PBPC suspensions are mixed in a 1:1 ratio and carefully frozen to liquid nitrogen temperatures. For reinfusion, cells are thawed at the bedside and used immediately. An intervening washing step is not possible due to increased cellular fragility. While some centers, including ours, are attempting to eliminate DNAse from the cryopreservation of unmanipulated cells, the utility of this agent, including the recombinant human form, for more complex manipulations of the cells (such as purging) may still be significant. 14 The potential risk of anaphylactic reactions to bovine DNAse should be weighed against the utility of the agent and its relative cost compared to the recombinant human form.
A number of significant points may be made from these data. First, our results argue against the hypothesis that DMSO may provoke in vitro histamine release and in vivo anaphylaxis, and support the search for alternative etiologies in such instances.
6,7 Second, since true anaphylaxis requires an initial sensitizing exposure to the antigen in order to generate antigen-specific IgE, it is interesting that this patient should develop anaphylaxis with her first infusion of PBPCs. However, the patient reported extensive exposure to bovine serum proteins commensurate with an extensive background in biomedical research. Thus, multiple opportunities for sensitization by the parenteral or inhalational route existed prior to her first PBPC infusion. Third, the ability of bovine DNAse to elicit a skin test Immunol 1996; 97: 42-46. 9 Adkinson NF Jr. Measurement of total serum immunoglobulin E and allergen-specific immunoglobulin E antibody. In: Rose
